Issue 46 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

FDA Finds Lapses in Reporting of Patient Harm, Deaths Resulting from Medical Devices in Hospitals Nationwide

FDA: For Hospitals that Significantly Violated Federal Adverse Event Reporting Requirement, No Additional Action Necessary

Hackensack Cancer Center, MSKCC Form Business, Clinical Partnership in New Jersey

Obama Signs Cures Act, Funding Biden's Moonshot and Boosting NIH, NCI, FDA Budgets Over 10 Years

The Year of the Moonshot

In Brief

Bertagnolli Elected ASCO President

CMS abandons Medicare Part B payment experiment

Maki joins leadership of Northwell Health and Cold Spring Harbor

Neufeld named clinical director, physician-in-chief & EVP at St. Jude

Anderson appointed CEO of Genentech

Brown gives $30 million to IU immunotherapy center

Mulva family donates $75 million to UT Austin, MD Anderson

Collins receives FASEB Public Service Award

Proton Partners to build new cancer center at Thames Valley Science Park, UK

ACCC launches online resource for metastatic breast cancer

Drugs & Targets

Keytruda becomes first anti-PD-1 therapy to receive a CHMP positive opinion for previously untreated NSCLC

Nintedanib receives orphan drug designation for mesothelioma

ABTL0812 receives orphan drug designation for Pancreatic Cancer

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login